BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysacc…
Biotechnology
US, San Rafael [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer GroupA quick analysis that compared BioMarin Pharmaceutical Inc. (BMRN) to it's peer group, including competitors as well as it's industry. All monetary values in mil. except volume - volume is in thousands.
| Company | Price | Change | Volume, Avg. | Market Cap. | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biotechnology Average | - - | - - | - - | 13,560.64 | 944.31 | 151.32 | 494.45 | 20.74 | 0.00 | 25.6171 | -0.86 | -1.0133 | -23.1680 | -0.09 | -0.08 | 7.2213 | - - | ||
| Maximum | - - | - - | - - | 444,129.00 | 65,349.00 | 25,407.00 | 99,050.00 | 5,305.00 | 0.02 | 1,336.3467 | 6.70 | 3.0051 | 85.3485 | 0.38 | 8.35 | 61.5621 | - - | ||
| Minimum | - - | - - | - - | 0.00 | 0.00 | -6,783.00 | -56,335.00 | -2,077.00 | 0.00 | -164.8536 | -57.22 | -101.7758 | -1,444.7800 | -1.56 | -12.64 | 0.0007 | - - | ||
| Apellis Pharmaceuticals, Inc. APLS | 27.75 | 0.26 0.95% | 1,488 vs. 2,868 | 3,451.00 | 172.00 | -66.00 | -133.00 | -2,903.00 | -0.5400 | -27.6326 | 0.0000 | 0.8802 | -0.3855 | -0.2491 | -0.0798 | 2.7985 | 124.00 | ||
| Seagen Inc. SGEN | 228.74 | -0.16 -0.07% | 19,392 vs. 1,634 | 43,154.00 | 648.00 | -215.00 | -79.00 | -2,756.00 | -1.1500 | -46.2406 | 0.0000 | 0.7452 | -0.3327 | -0.0846 | -0.0594 | 1.9572 | 188.00 | ||
| Bio-Techne Corporation TECH | 71.05 | 2.33 3.39% | 1,303 vs. 915 | 11,289.00 | 303.00 | 49.00 | 64.00 | 1,297.00 | 0.3100 | 55.6413 | 0.0012 | 0.6764 | 0.1617 | 0.0244 | 0.0180 | 2.4910 | 158.00 | ||
| IVERIC bio, Inc. ISEE | 39.95 | 0.15 0.38% | 10,801 vs. 4,945 | 5,512.00 | 0.00 | -70.00 | -50.00 | -937.00 | -0.5200 | -11.8078 | 0.0000 | 0.0000 | 0.0000 | -0.1480 | -0.1151 | 15.2365 | 137.00 | ||
| Ionis Pharmaceuticals, Inc. IONS | 33.94 | -1.46 -4.12% | 1,836 vs. 1,635 | 5,359.00 | 119.00 | -142.00 | -155.00 | -1,938.00 | -0.9800 | -11.1954 | 0.0000 | 0.9347 | -1.1950 | -0.4816 | -0.0517 | 6.7492 | 157.00 | ||
| Halozyme Therapeutics, Inc. HALO | 45.70 | -0.06 -0.13% | 1,268 vs. 1,580 | 5,814.00 | 195.00 | 76.00 | 125.00 | 167.00 | 0.6100 | 17.0691 | 0.0000 | 0.7647 | 0.3922 | 0.4321 | 0.0417 | 5.0088 | 127.00 | ||
| Exelixis, Inc. EXEL | 34.83 | 0.18 0.52% | 1,318 vs. 2,065 | 9,946.00 | 425.00 | 37.00 | 50.00 | -258.00 | 0.1200 | 47.8131 | 0.0000 | 0.9500 | 0.0878 | 0.0175 | 0.0133 | 3.2273 | 285.00 | ||
| Karuna Therapeutics, Inc. KRTX | 329.83 | 0.09 0.03% | 1,283 vs. 971 | 12,599.00 | 0.00 | -113.00 | -111.00 | -997.00 | -3.0100 | -26.2644 | 0.0000 | 0.0000 | 0.0000 | -0.0908 | -0.0852 | 18.6075 | 38.00 | ||
| Arrowhead Pharmaceuticals, Inc. ARWR | 18.28 | -0.43 -2.30% | 743 vs. 1,061 | 2,272.00 | 0.00 | -125.00 | -126.00 | -1,284.00 | -1.0200 | -6.9465 | 0.0000 | 0.0000 | 0.0000 | -0.2590 | -0.1312 | 8.0263 | 124.00 | ||
| Blueprint Medicines Corporation BPMC | 96.62 | 1.81 1.91% | 741 vs. 620 | 6,137.00 | 96.00 | 89.00 | -102.00 | -2,250.00 | 1.4500 | 16.6530 | 0.0000 | 0.9168 | 0.9274 | 0.2869 | 0.0858 | 3.4266 | 63.00 | ||
| Incyte Corporation INCY | 70.39 | -0.66 -0.93% | 2,109 vs. 2,066 | 13,560.00 | 880.00 | 169.00 | 209.00 | 329.00 | 0.7600 | 18.7480 | 0.0000 | 0.9308 | 0.1925 | 0.0314 | 0.0238 | 3.2913 | 192.00 | ||
| BioMarin Pharmaceutical Inc. BMRN | 63.45 | 0.89 1.42% | 1,230 vs. 1,774 | 12,092.00 | 648.00 | 88.00 | 12.00 | -532.00 | 0.4700 | 46.3847 | 0.0000 | 0.7850 | 0.1366 | 0.0175 | 0.0129 | 1.5477 | 190.00 | ||
| Alnylam Pharmaceuticals, Inc. ALNY | 246.80 | -1.99 -0.80% | 676 vs. 859 | 31,832.00 | 494.00 | -65.00 | -94.00 | -7,075.00 | -0.5200 | -73.3326 | 0.0000 | 0.8665 | -0.1334 | 0.3007 | -0.0172 | 2.8593 | 128.00 | ||
| Vaxcyte, Inc. PCVX | 88.39 | 2.43 2.83% | 1,980 vs. 1,214 | 11,016.00 | 0.00 | -95.00 | -171.00 | -1,019.00 | -0.8500 | -19.6094 | 0.0000 | 0.0000 | 0.0000 | -0.0479 | -0.0454 | 17.2498 | 124.00 | ||
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.